[Gemcitabine treatment of pancreatic cancer peritonitis].
Horiki
Noriyuki
N
Division of Internal Medicine, St. Luke's International Hospital, Division of Gastroenterology, National Mie Chuo Hospital, 3rd Department of Internal Medicine, Mie University.
Maruyama
Masataka
M
Fujita
Yoshiyuki
Y
Suzuki
Yuko
Y
Tanaka
Tsuyoshi
T
Shimomura
Makoto
M
Tanigawa
Kanji
K
Sasaki
Hidehito
H
Fujiwara
Mieko
M
Suzuki
Kouyou
K
Imoto
Ichiro
I
Adachi
Yukihiko
Y
D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy*; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine